Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.
Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.0%
- Check34 days agoNo Change Detected
- Check47 days agoChange DetectedThe website has updated the 'Last Update Posted' information, removing the 'Estimated' qualifier.SummaryDifference0.0%
- Check48 days agoChange DetectedThe latest update includes new data on the efficacy of Nusinersen in treating both infantile-onset and later-onset SMA, with multiple comparisons against control groups for various motor milestone assessments and survival outcomes, while several previous entries have been removed.SummaryDifference15%
- Check55 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check69 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the web page.SummaryDifference0.0%
Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.